• Maximiliano Servin-Rojas, Antonio Olivas-Martinez, Ramirez Del ValFernandoF0000-0001-7351-9194Department of Surgery, Houston Methodist Hospital, Houston, Texas, USA., Armando Torres-Gomez, Luis Navarro-Vargas, and Ignacio García-Juárez.
• Faculty of Medicine, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico.
• Am. J. Transplant. 2021 Dec 1; 21 (12): 4052-4060.

AbstractHealthcare systems worldwide were challenged during the COVID-19 pandemic. In Mexico, the public hospitals that perform most transplants were adapted to provide care for COVID-19 patients. Using a nationwide database, we describe the first report of the impact of COVID-19 and related transplantation healthcare policies in a middle-income country by comparing statistics before and during the pandemic (pre-COVID: March 2019-February 2020 vs. COVID era: March 2020-February 2021) and by type of institution (public vs. private). The global reduction in transplantation was higher in public institutions compared with private institutions, 89% versus 62%, respectively, p < .001. When analyzing by organ, kidney transplantation decreased by 89% at public versus 57% at private, p < .001; cornea by 88% at public versus 64% at private, p < .001; liver by 88% at public versus 35% at private, p < .001; and heart by 88% in public versus 67% at private institutions, p = .4. The COVID-19 pandemic along with the implemented health policies were associated with a decrease in donations, waiting list additions, and a decrease in transplantation, particularly at public institutions, which care for the most vulnerable.© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

13 keywords...

hide…